Suspension of trading
Quotes eFFECTOR Therapeutics, Inc. Deutsche Boerse AG
Stocks
LWK1
US28202V1089
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.075 EUR | +0.47% |
|
-8.12% | -88.97% |
| 24-09-10 | Tyra Biosciences Names Doug Warner Chief Medical Officer | MT |
| 24-07-07 | EFFECTOR Therapeutics, Inc.(OTCPK:EFTR) dropped from S&P TMI Index | CI |
Performance
| 1 week | -8.12% | ||
| 1 month | -34.45% | ||
| 6 months | -88.32% | ||
| Current year | -88.97% | ||
| 1 year | -94.23% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (EUR)
940
Market Cap (USD)
940
Net sales (USD)
-
Free-Float
99.75 %
Free-Float capitalization (EUR)
1,070
Free-Float capitalization (USD)
940
Indicators
Moving average 5 days
1.081
Moving average 100 days
1.66
Price spread / (MMA5)
+0.56%
Price spread / (MMA100)
+54.40%
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.47% | -8.12% | -94.23% | - | 940 | |
| -3.74% | -6.32% | +42.70% | +63.37% | 55.2B | |
| -0.81% | -0.33% | +27.15% | +81.12% | 55.6B | |
| -0.72% | +0.22% | -16.17% | -15.26% | 23.51B | |
| -3.15% | -6.70% | -4.73% | +353.64% | 22.35B | |
| -4.01% | -2.68% | +12.50% | -12.70% | 20.6B | |
| -1.23% | -3.15% | +26.00% | -33.84% | 17.45B | |
| -3.34% | -6.96% | +22.02% | +515.48% | 15.16B | |
| -0.22% | -1.01% | +49.48% | +179.50% | 13.91B | |
| -5.09% | -13.14% | +151.85% | +272.20% | 13.74B | |
| Average | -2.52% | -1.55% | +21.66% | +155.95% | 23.75B | |
| Weighted average by Cap. | -2.41% | -0.46% | +30.31% | +121.06% |
Historical Quotes: eFFECTOR Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 1 week | 1.06 |  | 1.14 |
| 1 month | 1.06 | | 1.62 |
Monthly variations
Annual variations
| 2024 | -88.97% | ||
| 2023 | +2.63% | ||
| 2022 | -94.61% |
- Stock Market
- Stocks
- EFTR Stock
- LWK1 Stock
- Quotes eFFECTOR Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
